ATE308551T1 - Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten - Google Patents

Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten

Info

Publication number
ATE308551T1
ATE308551T1 AT00956040T AT00956040T ATE308551T1 AT E308551 T1 ATE308551 T1 AT E308551T1 AT 00956040 T AT00956040 T AT 00956040T AT 00956040 T AT00956040 T AT 00956040T AT E308551 T1 ATE308551 T1 AT E308551T1
Authority
AT
Austria
Prior art keywords
oligosaccharides
ribtol
ribose
phosphate
vaccines containing
Prior art date
Application number
AT00956040T
Other languages
English (en)
Inventor
Bencomo Vicente Guillerm Verez
Centro Habana Peregrino
Rene Roy
Original Assignee
Univ La Habana
Univ Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Habana, Univ Ottawa filed Critical Univ La Habana
Application granted granted Critical
Publication of ATE308551T1 publication Critical patent/ATE308551T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/08Polyoxyalkylene derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT00956040T 1999-08-30 2000-08-15 Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten ATE308551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1999121A CU22904A1 (es) 1999-08-30 1999-08-30 Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
PCT/CU2000/000003 WO2001016146A1 (es) 1999-08-30 2000-08-15 Oligosacáridos derivados de ribosa-ribitol-fosfato y vacunas que los contienen

Publications (1)

Publication Number Publication Date
ATE308551T1 true ATE308551T1 (de) 2005-11-15

Family

ID=5459405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956040T ATE308551T1 (de) 1999-08-30 2000-08-15 Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten

Country Status (24)

Country Link
US (1) US6765091B1 (de)
EP (1) EP1212334B1 (de)
JP (1) JP4850377B2 (de)
KR (1) KR100818163B1 (de)
CN (1) CN1205217C (de)
AR (1) AR025435A1 (de)
AT (1) ATE308551T1 (de)
AU (1) AU780816B2 (de)
BR (1) BRPI0013686B8 (de)
CA (1) CA2382602C (de)
CO (1) CO5180646A1 (de)
CU (1) CU22904A1 (de)
CZ (1) CZ2002721A3 (de)
DE (1) DE60023722T2 (de)
DK (1) DK1212334T3 (de)
EA (1) EA005381B1 (de)
ES (1) ES2252045T3 (de)
HK (1) HK1050693A1 (de)
MX (1) MXPA02002066A (de)
NZ (1) NZ517464A (de)
SI (1) SI1212334T1 (de)
UA (1) UA75579C2 (de)
WO (1) WO2001016146A1 (de)
ZA (1) ZA200201667B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713508A2 (de) * 2004-01-29 2006-10-25 Biosynexus Incorporated Verwendung von aminoox-funktionalen gruppen bei der herstellung von vakzine-konjugaten
US8647621B2 (en) 2009-07-27 2014-02-11 Fina Biosolutions, Llc Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
RU2558257C2 (ru) 2009-07-31 2015-07-27 Нэшнл Рисерч Каунсл Оф Канада ВНЕШНИЙ КОРОВОЙ ЭПИТОП ЛИПОПОЛИСАХАРИДА Н. pylori
US9044517B2 (en) 2009-12-17 2015-06-02 Fina Biosolutions, Llc Activation of polysaccharides via the cyanylating agent, 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), in the preparation of polysaccharide/protein conjugate vaccines
WO2011133191A1 (en) * 2010-04-23 2011-10-27 Serum Institute Of India, Ltd. Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels
JP6784841B2 (ja) 2016-07-28 2020-11-11 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー ヘモフィルス属インフルエンザ菌b型に対するワクチンとしての安定した加水分解耐性合成ポリリボシルリビトールホスフェート誘導体
KR20200141053A (ko) * 2018-03-23 2020-12-17 코라넥스 캐피탈 치료 도구로서의 정밀 당 접합체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (de) * 1987-12-18 1989-10-04 American Cyanamid Company Polysaccharide und makromolekulare Verbindungen davon
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae

Also Published As

Publication number Publication date
CA2382602A1 (en) 2001-03-08
JP2003528032A (ja) 2003-09-24
CN1376158A (zh) 2002-10-23
AR025435A1 (es) 2002-11-27
EP1212334B1 (de) 2005-11-02
CZ2002721A3 (cs) 2002-07-17
MXPA02002066A (es) 2004-07-30
NZ517464A (en) 2004-03-26
KR100818163B1 (ko) 2008-03-31
CN1205217C (zh) 2005-06-08
JP4850377B2 (ja) 2012-01-11
BRPI0013686B1 (pt) 2016-07-26
WO2001016146A1 (es) 2001-03-08
ES2252045T3 (es) 2006-05-16
AU6817300A (en) 2001-03-26
EA005381B1 (ru) 2005-02-24
DK1212334T3 (da) 2006-03-20
CU22904A1 (es) 2004-01-23
EA200200314A1 (ru) 2002-10-31
HK1050693A1 (en) 2003-07-04
EP1212334A1 (de) 2002-06-12
DE60023722D1 (de) 2005-12-08
BRPI0013686B8 (pt) 2021-05-25
UA75579C2 (en) 2006-05-15
US6765091B1 (en) 2004-07-20
DE60023722T2 (de) 2006-07-20
SI1212334T1 (sl) 2006-04-30
AU780816B2 (en) 2005-04-21
CO5180646A1 (es) 2002-07-30
CA2382602C (en) 2010-02-16
BR0013686A (pt) 2002-08-13
KR20020068501A (ko) 2002-08-27
ZA200201667B (en) 2003-08-27

Similar Documents

Publication Publication Date Title
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
DE60122193D1 (de) Glucopyranosyloxybenzylbenzol derivate und medizinische zusammensetzungen, die diese verbindungen enthalten
ZA200202996B (en) Hair treatment compositions comprising particulate substances.
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HK1022439A1 (en) Pharmaceutical compositions containing lactobacilli for treatment fo vaginal infections
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
ATE327978T1 (de) Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
FR2773804B1 (fr) Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
DE60030845D1 (de) Arzneimittel, lebensmittel und orale zusammensetzungen die stilben-artige verbindungen enthalten
ATE298569T1 (de) Virus behandlung
ATE308551T1 (de) Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten
ATE250570T1 (de) Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten
DE69529090T2 (de) Polymerisierbare verbindungen und zusammensetzungen
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
DE69931038D1 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten
ID29219A (id) (1-fenasi-3-fenil-3-piperidiletil): turunan-turunan piperidin, proses untuk memperolehnya dan komposisi-komposisi farmasi
DZ2867A1 (fr) Compositions pharmaceutiques comprenant des inhibiteurs de nos, leur préparation et leur utilisation.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
HU0001891D0 (en) Medicament for the treatment of migraine
DE60001336D1 (de) Antiseptisches/fungizides Mittel und endermatische Salbe, die es enthalten
DE60011060D1 (de) Virus behandlung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1212334

Country of ref document: EP